首页 | 本学科首页   官方微博 | 高级检索  
检索        

噻托溴铵联合阿奇霉素治疗老年人慢性阻塞性肺疾病的疗效及对肺功能的影响
引用本文:韩应前.噻托溴铵联合阿奇霉素治疗老年人慢性阻塞性肺疾病的疗效及对肺功能的影响[J].中国基层医药,2014(20):3076-3077.
作者姓名:韩应前
作者单位:中信机电制造公司总医院呼吸科,山西省运城043800
摘    要:目的:探讨噻托溴铵联合阿奇霉素治疗老年人COPD的临床疗效及对肺功能的影响。方法将100例老年COPD患者采用随机数字表法分为两组,每组各50例,其中对照组给予噻托溴铵治疗,观察组采取噻托溴铵联合阿奇霉素治疗,比较两组临床疗效及肺功能各项指标变化。结果观察组治疗后Borg评分和6 min步行距离(6MWD)分别为(2.31±0.17)分和(380.13±15.07) m,均较治疗前的(3.17±0.26)分和(270.41±13.03)m及对照组的(2.84±0.25)分和(320.18±14.78)m显著改善(t=6.84、8.56、7.90、8.73、7.79、8.21,均P<0.05);观察组治疗后FVC、FEV1和FEV1/FVC 分别为(2.54±0.44) L、(2.13±0.35)L和(72.38±5.61)%,均较治疗前的(1.63±0.37)L、(1.24±0.24)L和(47.30±5.48)%及对照组的(2.18±0.39)L、(1.69±0.35)L和(61.66±5.32)%显著增加(t=6.35、7.76、7.02、8.04、7.14、7.95、6.91、7.41、7.60,均P<0.05)。结论噻托溴铵联合阿奇霉素治疗老年COPD疗效显著,且能明显改善患者肺功能,具有较好的临床应用价值。

关 键 词:肺疾病  慢性阻塞性  肺功能  噻托溴铵  阿奇霉素  老年人

The clinical efficacy of tiotropium bromide combined with azithromycin in the treatment of elderly patients with chronic obstructive pulmonary disease and its effects on pulmonary function
Han Yingqian.The clinical efficacy of tiotropium bromide combined with azithromycin in the treatment of elderly patients with chronic obstructive pulmonary disease and its effects on pulmonary function[J].Chinese Journal of Primary Medicine and Pharmacy,2014(20):3076-3077.
Authors:Han Yingqian
Institution:Han Yingqian( Department of Respiratory Disease, the General Hospital of Mechanical and Electrical Manufacturing Company, Yuncheng , Shanxi 043800, China)
Abstract:Objective To investigate the clinical curative effect of tiotropium bromide combined with azithro -mycin in the treatment of elderly patients with chronic obstructive pulmonary disease ( COPD) and its effect on lung function.Methods 100 senile COPD patients were randomly divided into the two groups ,50 cases in each group.The control group was given tiotropium therapy , while the observation group used tiotropium bromide combined with azithromycin.The clinical efficacy and pulmonary function indices were compared between the two groups .Results Borg score and 6min walking distance (6MWD) of the observation group after treatment were (2.31 ±0.17) points and (380.13 ±15.07)m,which were significantly better than (3.17 ±0.26)points,(270.41 ±13.03)m of before treatment and (2.84 ±0.25)points,(320.18 ±14.78)m of the control group (t=6.84,8.56,7.90,8.73,7.79, 8.21,all P〈0.05);FVC,FEV1 and FEV1/FVC of the observation group after treatment were (2.54 ±0.44) L, (2.13 ±0.35)L and (72.38 ±5.61)%,which were significantly higher than (1.63 ±0.37)L,(1.24 ±0.24)L and (47.30 ±5.48)%before treatment and (2.18 ±0.39) L,(1.69 ±0.35) L and (61.66 ±5.32)% of the control group (t=6.35,7.76,7.02,8.04,7.14,7.95,6.91,7.41,7.60,all P〈0.05).Conclusion Tiotropium bromide combined with azithromycin has significant curative effect in the treatment of senile COPD and can obviously improve the pulmonary function of patients ,which has good clinical application value .
Keywords:Pulmonary disease  chronic obstructive  Pulmonary function  Tiotropium  Azithromycin  Aged
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号